MELISSA HUGHES: Open Payments
NPI 1144898933 · KINGSBURG, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,577 in 13 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,228 · 2025 $1,577
Food & beverage: $1,577
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $268 |
| Alnylam Pharmaceuticals Inc. | 1 | $150 |
| Eisai Inc. | 1 | $125 |
| ARGENX US, INC. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $123 |
| Exact Sciences Corporation | 1 | $122 |
| ABIOMED | 1 | $119 |
| ACADIA Pharmaceuticals Inc | 1 | $113 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $111 |
Products named: REZDIFFRA, ONPATTRO, Leqembi, VYVGART, Wegovy, XIFAXAN, The Cologuard Plus Collection Kit, NUPLAZID.
Industry payments across CA — which companies pay providers there.
